3.2.1.123	2-N-hexadecanoylamino-4-nitrophenyl-O-beta-lactoside + H2O	-	Corynebacterium sp.	N-(2-hydroxy-5-nitrophenyl)hexadecanamide + beta-lactose	-	?	361202	
3.2.1.123	2-N-hexadecanoylamino-4-nitrophenyl-O-beta-lactoside + H2O	derivative possessing an N-acyl chain, 4-nitrophenyllactoside chromogenic substrate C16ampNPLac	Rhodococcus sp.	N-(2-hydroxy-5-nitrophenyl)hexadecanamide + beta-lactose	-	?	361202	
3.2.1.123	4-methylumbelliferyl beta-D-glucoside + H2O	-	Cryptococcus neoformans	4-methylumbelliferone + beta-D-glucose	-	?	364701	
3.2.1.123	4-methylumbelliferyl beta-D-glucoside + H2O	-	Cryptococcus neoformans H99	4-methylumbelliferone + beta-D-glucose	-	?	364701	
3.2.1.123	4-nitrophenyl alpha-D-glucoside + H2O	low activity	Cryptococcus neoformans	4-nitrophenol + alpha-D-glucose	-	?	431382	
3.2.1.123	4-nitrophenyl alpha-D-glucoside + H2O	low activity	Cryptococcus neoformans H99	4-nitrophenol + alpha-D-glucose	-	?	431382	
3.2.1.123	4-nitrophenyl beta-D-glucoside + H2O	high activity	Cryptococcus neoformans	4-nitrophenol + beta-D-glucose	-	?	364700	
3.2.1.123	4-nitrophenyl beta-D-glucoside + H2O	high activity	Cryptococcus neoformans H99	4-nitrophenol + beta-D-glucose	-	?	364700	
3.2.1.123	7-nitro-2,1,3-benzoxadiazole-pentanol + digalactosyldiacylglycerol	transglycosylation	Rhodococcus equi	?	-	?	408236	
3.2.1.123	alpha-L-Fuc-(1->2)-beta-D-Gal-(1->3)-beta-D-GalNAc-(1->4)-(alpha-Neu5Ac-(2->3))-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-ceramide + H2O	-	Rhodococcus equi	ceramide + alpha-L-Fuc-(1->2)-beta-D-Gal-(1->3)-beta-D-GalNAc-(1->4)-(alpha-Neu5Ac-(2->3))-beta-D-Gal-(1->4)-beta-D-Glc	-	?	446971